Skip to search formSkip to main contentSkip to account menu

zaprinast

Known as: 2-(2-propoxyphenyl)-8-azapurin-6-one, 2-o-propoxyphenyl-8-azapurine-6-one 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
The duration of cell death may allow deducing the underlying degenerative mechanism. To find out how long a photoreceptor takes… 
2011
2011
Cyclic nucleotide phosphodiesterases (PDEs) are enzymes that regulate the cellular levels of the second messengers, cAMP and cGMP… 
2006
2006
Objective To investigate the effect of zaprinast (a phosphodiesterase-5 inhibitor) on cerebral blood flow during the acute… 
2004
2004
i I THE NEUROPROTECTIVE PROPERTIES OF SlLDENAFlL AND ITS MODULATING EFFECTS ON MUSCARlNlC ACETYLCHOLINE RECEPTOR FUNCTION Since… 
2001
2001
The effects of exogenous cyclic nucleotides and modulators of the cyclic nucleotide signaling pathway on the step-up photophobic… 
1999
1999
Abstract : The role of 3′,5′‐cyclic guanosine monophosphate (cGMP) in the activation of mitogen‐activated protein kinases (MAPKs… 
1999
1999
Sobey, Christopher G., and Lilly Quan. Impaired cerebral vasodilator responses to NO and PDE V inhibition after subarachnoid… 
1997
1997
The effects of various selective phosphodiesterase (PDE) inhibitors on muscle contractility in guinea pig ileal longitudinal… 
1994
1994
1 The ability of various phosphodiesterase (PDE) inhibitors to reduce the initial and/or late response to ovalbumin (OVA) in…